JBIO - Aerovate Therapeutics, Inc.
14.05
0.170 1.210%
Share volume: 299,346
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$13.88
0.17
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 04-25-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 106.821 M | 111.694 M | 90.959 M | 80.332 M | 77.533 M | 202.450 M | |
| Current Assets | 103.239 M | 110.760 M | 90.605 M | 80.117 M | 77.373 M | 201.360 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 90.212 M | 73.133 M | 57.615 M | 44.872 M | 31.990 M | 148.799 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.122 M | 31.069 M | 31.115 M | 33.751 M | 44.220 M | 50.106 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 260.000 K | 232.000 K | 14.000 K | 6.000 K | 2.000 K | 176.000 K | |
| Other Assets | 3.322 M | 702.000 K | 340.000 K | 209.000 K | 158.000 K | 914.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 106.821 M | 111.694 M | 90.959 M | 80.332 M | 77.533 M | 202.450 M | |
| Total liabilities | 15.917 M | 17.296 M | 10.466 M | 3.898 M | 2.487 M | 23.104 M | |
| Total current liabilities | 15.518 M | 17.020 M | 10.315 M | 3.828 M | 2.417 M | 22.357 M | |
| Accounts Payable | 3.313 M | 4.179 M | 908.000 K | 224.000 K | 69.000 K | 1.350 M | |
| Other liabilities | 399.000 K | 276.000 K | 151.000 K | 70.000 K | 70.000 K | 747.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 399.000 K | 276.000 K | 151.000 K | 70.000 K | 70.000 K | 747.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 90.904 M | 94.398 M | 80.493 M | 76.434 M | 75.046 M | 179.344 M | |
| Common stock | 277.547 M | 305.866 M | 307.891 M | 309.381 M | 310.566 M | 321.772 M | |
| Retained earnings | -186.610 M | -211.385 M | -227.622 M | -233.052 M | -235.570 M | -142.457 M |